Literature DB >> 27690385

Small-Molecule Probes Reveal Esterases with Persistent Activity in Dormant and Reactivating Mycobacterium tuberculosis.

Katie R Tallman1, Samantha R Levine1, Kimberly E Beatty1.   

Abstract

Mycobacterium tuberculosis (Mtb) is the deadliest bacterial pathogen in the world. An estimated one-third of humans harbor Mtb in a dormant state. These asymptomatic, latent infections impede tuberculosis eradication due to the long-term potential for reactivation. Dormant Mtb has reduced enzymatic activity, but hydrolases that remain active facilitate pathogen survival. We targeted Mtb esterases, a diverse set of enzymes in the serine hydrolase family, and studied their activities using both activity-based probes (ABPs) and fluorogenic esterase substrates. These small-molecule probes revealed functional esterases in active, dormant, and reactivating cultures. Using ABPs, we identified five esterases that remained active in dormant Mtb, including LipM (Rv2284), LipN (Rv2970c), CaeA (Rv2224c), Rv0183, and Rv1683. Three of these, CaeA, Rv0183, and Rv1683, were catalytically active in all three culture conditions. Fluorogenic probes additionally revealed LipH (Rv1399c), Culp1 (Rv1984c), and Rv3036c esterase activity in dormant and active cultures. Esterases with persistent activity are potential diagnostic biomarkers or therapeutic targets for Mtb-infected individuals with latent or active tuberculosis.

Entities:  

Keywords:  Mycobacterium tuberculosis; chemical biology; esterase; fluorescent; proteomics

Mesh:

Substances:

Year:  2016        PMID: 27690385     DOI: 10.1021/acsinfecdis.6b00135

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  23 in total

1.  Fluorogenic structure activity library pinpoints molecular variations in substrate specificity of structurally homologous esterases.

Authors:  Alex White; Andrew Koelper; Arielle Russell; Erik M Larsen; Charles Kim; Luke D Lavis; Geoffrey C Hoops; R Jeremy Johnson
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

2.  Investigating β-Lactam Drug Targets in Mycobacterium tuberculosis Using Chemical Probes.

Authors:  Samantha R Levine; Kimberly E Beatty
Journal:  ACS Infect Dis       Date:  2021-01-20       Impact factor: 5.084

3.  Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).

Authors:  Pooja V Hegde; Michael D Howe; Matthew D Zimmerman; Helena I M Boshoff; Sachin Sharma; Brianna Remache; Ziyi Jia; Yan Pan; Anthony D Baughn; Veronique Dartois; Courtney C Aldrich
Journal:  Eur J Med Chem       Date:  2022-02-19       Impact factor: 6.514

4.  Total Synthesis of Tetrahydrolipstatin, Its Derivatives, and Evaluation of Their Ability to Potentiate Multiple Antibiotic Classes against Mycobacterium Species.

Authors:  Saniya S Khan; Thanuja D Sudasinghe; Alexander D Landgraf; Donald R Ronning; Steven J Sucheck
Journal:  ACS Infect Dis       Date:  2021-09-03       Impact factor: 5.578

5.  Ester-prodrugs of ethambutol control its antibacterial activity and provide rapid screening for mycobacterial hydrolase activity.

Authors:  Erik M Larsen; Dominique C Stephens; Nathan H Clarke; R Jeremy Johnson
Journal:  Bioorg Med Chem Lett       Date:  2017-08-30       Impact factor: 2.823

Review 6.  Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities.

Authors:  Laura J Keller; Brett M Babin; Markus Lakemeyer; Matthew Bogyo
Journal:  Curr Opin Chem Biol       Date:  2019-12-10       Impact factor: 8.822

7.  Measuring the Global Substrate Specificity of Mycobacterial Serine Hydrolases Using a Library of Fluorogenic Ester Substrates.

Authors:  Braden Bassett; Brent Waibel; Alex White; Heather Hansen; Dominique Stephens; Andrew Koelper; Erik M Larsen; Charles Kim; Adam Glanzer; Luke D Lavis; Geoffrey C Hoops; R Jeremy Johnson
Journal:  ACS Infect Dis       Date:  2018-04-16       Impact factor: 5.084

Review 8.  Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.

Authors:  Erik M Larsen; R Jeremy Johnson
Journal:  Drug Dev Res       Date:  2018-10-10       Impact factor: 4.360

Review 9.  Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery.

Authors:  Divya Awasthi; Joel S Freundlich
Journal:  Trends Microbiol       Date:  2017-06-13       Impact factor: 17.079

10.  Chemiluminescent Protease Probe for Rapid, Sensitive, and Inexpensive Detection of Live Mycobacterium tuberculosis.

Authors:  Brett M Babin; Gabriela Fernandez-Cuervo; Jessica Sheng; Ori Green; Alvaro A Ordonez; Mitchell L Turner; Laura J Keller; Sanjay K Jain; Doron Shabat; Matthew Bogyo
Journal:  ACS Cent Sci       Date:  2021-04-14       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.